Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial isolated dilated cardiomyopathy in which the cause of the disease is a mutation in the PLN gene.
Features include always present findings: Enlarged and weakened heart (dilated cardiomyopathy); and common findings: Congestive heart failure. 4 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 4 | Congestive heart failure, Reduced systolic function, Ventricular arrhythmia |
PLN function has not been fully characterized.
Dilated cardiomyopathy 1P is associated with mutations in the PLN gene on chromosome 6.
Genetic testing for PLN is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for dilated cardiomyopathy 1P has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 common feature.
No clinical trials have been registered for dilated cardiomyopathy 1P.
27 publications have been identified in PubMed for dilated cardiomyopathy 1P. Research spans Diagnostic / Biomarker (41%), Clinical Trial Publication (19%), and Case Report / Case Series (11%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 11 | 41% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:06 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Clinical study results
5 |
19% |
Patient case studies | 3 | 11% |
Laboratory research | 3 | 11% |
Disease patterns and progression | 3 | 11% |
Research summaries | 2 | 7% |
Abramowitz SA (2026). [PMID: 41433035](https://pubmed.ncbi.nlm.nih.gov/41433035/). *JAMA cardiology*. [Epidemiology / Natural History]
Panaioli E (2026). [PMID: 41319813](https://pubmed.ncbi.nlm.nih.gov/41319813/). *International journal of cardiology*. [Epidemiology / Natural History]
Peretto G (2026). [PMID: 40678978](https://pubmed.ncbi.nlm.nih.gov/40678978/). *European heart journal*. [Diagnostic / Biomarker]
Di Gioia G (2026). [PMID: 40930242](https://pubmed.ncbi.nlm.nih.gov/40930242/). *American heart journal*. [Diagnostic / Biomarker]
Moon J (2026). [PMID: 40602507](https://pubmed.ncbi.nlm.nih.gov/40602507/). *The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation*. [Clinical Trial Publication]
Rame JE (2025). [PMID: 40660878](https://pubmed.ncbi.nlm.nih.gov/40660878/). *European journal of heart failure*. [Clinical Trial Publication]
Ponzoni M (2025). [PMID: 40536467](https://pubmed.ncbi.nlm.nih.gov/40536467/). *JACC. Basic to translational science*. [Basic Science / Preclinical]
Krawiec M (2025). [PMID: 40901530](https://pubmed.ncbi.nlm.nih.gov/40901530/). *Frontiers in pediatrics*. [Case Report / Case Series]
Chen Y (2025). [PMID: 40893531](https://pubmed.ncbi.nlm.nih.gov/40893531/). *Quantitative imaging in medicine and surgery*. [Diagnostic / Biomarker]
Mui D (2025). [PMID: 40841467](https://pubmed.ncbi.nlm.nih.gov/40841467/). *The international journal of cardiovascular imaging*. [Diagnostic / Biomarker]